ODDB.org: Open Drug Database

Novartis Pharma Schweiz AG - Tasigna 200 mg, Kapseln

Swissmedic Registration	58007	Sequence	01
Product name	Tasigna 200 mg	Description	Kapseln
ATC-Classification	L01EA03	ATC-Description
Introduction of Sequence	24.07.2007

Composition

nilotinibum 200 mg ut nilotinibi hydrochloridum monohydricum, lactosum monohydricum 156.11 mg, crospovidonum, poloxamerum 188, silica colloidalis anhydrica, magnesii stearas, Kapselhülle: gelatina, E 171, E 172 (flavum), Drucktinte: lacca, propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, E 172 (rubrum), pro capsula.

Packungsbestandteile

Galenic Form

Capsules

Active Agent	Dose
Nilotinibum	200 mg

BAG: Active Agent	Dose
Nilotinibum	200 mg

Inactive agents	Dose	additional_information




		color.
		color.
Gelatina		Kapselhülle

		Drucktinte
Lactose Monohydrate	156.11 mg

Poloxamer	188

Propylenglycol
Silica Colloidalis Anhydrica

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
001	28 Capsule(s)	861.28	953.10	A	SL	No
002	112 Capsule(s)	2825.01	3088.80	A	SL	No

2025	©ywesee GmbH